Click here to close Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly. We suggest using a current version of Chrome, FireFox, or Safari.
Search Criteria
Gene/CloneSpeciesStageAnatomy ItemExperimenter
ergxenopus capillary 

Too many results?Too few results?

Experiment details for erg

Meadows SM et al. (2009) Assay

Kruppel-like factor 2 cooperates with the ETS family protein ERG to activate Flk1 expression during vascular development.

Gene Clone Species Stages Anatomy
erg.L laevis NF stage 33 and 34 capillary

Display additional annotations [+]
  Fig. 3. Inhibition of KLF2 function results in reduced Flk1 expression in the Xenopus embryo. (A-C) Whole-mount in situ hybridization analysis of Flk1, Erg and Klf2 expression in Xenopus embryos (stage 34, lateral view). For each gene, expression is observed in the endothelial cells of the major developing vessels, including the posterior cardinal vein (PCV), intersomitic vessels (IS), aortic arches (AA) and in the forming plexus on the flank of the embryo (PL). (D,E) Klf2 MO effectively blocks translation of a control Klf2 transcript. (D) Bright-field and fluorescent images of embryos injected with a control transcript in which the 5′ UTR of Klf2 was fused to the coding sequences of GFP (Klf2-GFP). (E) Bright-field and fluorescent images of embryos injected with Klf2-GFP transcript plus Klf2 MO (25 ng). Note that GFP reporter fluorescence is greatly inhibited by Klf2 MO treatment. (F) Embryo injected with 50 ng of a control MO and assayed for expression of Flk1 transcripts. The inset is a higher magnification view, centered on the developing posterior cardinal vein. (G,H) Two different embryos injected with 50 ng of Klf2 MO and assayed for expression of Flk1. Klf2 MO-injected embryos show a dramatic reduction of Flk1 expression. (I) Embryo injected with 500 pg of GFP mRNA and assayed for Flk1 transcripts. (J,K) Two different embryos injected with 250 pg of mRNA encoding a dominant-repressor form of KLF2 (DR-KLF2) and assayed for Flk1 transcripts. Embryos expressing the DR-KLF2 construction show a dramatic reduction of Flk1 transcripts. (L) qRT-PCR analysis reveals significant reduction in Flk1 transcript levels in Klf2 MO-treated embryos. Results shown are the average of three separate embryos for each MO treatment. (M-M′) Klf2 MO treatment eliminates vascular tubes. Histological section through a stage 42 embryo injected with Klf2 MO. Somites (s) and notochord (nc) are indicated. Scale bar: 100 μm. Injected side is to the right (arrowhead). M′ and M′ show enlargements of the region of the posterior cardinal vein on the untreated and treated sides, respectively. Although the pronephric duct (pnd) is visible on both sides, no tube corresponding to the posterior cardinal vein (pcv) is visible on the treated side.